NeoGenomics (NASDAQ:NEO) intends to build a cancer diagnostics testing facility and new global business headquarters in Fort Myers, Florida.
The new facility is expected to open in 2021.
The 150,000-square-foot laboratory and headquarters facility will also support clinical trials for new oncology therapeutics.
The Florida Department of Economic Opportunity and Lee County have offered the following economic support:
Florida state capital investment tax credits, tax refunds and Lee County community support.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.